(Q81403203)
Statements
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer (English)
Eleni Andreopoulou
Darci Gaiotti
Eugene Kim
Matthew Volm
Ruth Oratz
Robin Freedberg
Andrea Downey
Charles L Vogel